Literature DB >> 19912070

Polidocanol for endovenous microfoam sclerosant therapy.

David M Eckmann1.   

Abstract

BACKGROUND: Polidocanol is a liquid surfactant having endothelial cell lytic properties. In the form of a controlled, dispensed microfoam it is administered endovenously as a sclerosing agent in the treatment of varicose veins.
OBJECTIVE: This review summarizes efficacy of polidocanol endovenous microfoam sclerotherapy using a proprietary dispensing system to control foam characteristics and gas content for treating varicose veins.
METHODS: We reviewed in vitro, Phase I, Phase II and limited Phase III data for polidocanol microfoam with a focus on controlled foam formulation in therapy. RESULTS/
CONCLUSIONS: Clinical trials of controlled dispensing of polidocanol microfoam provide evidence of effective treatment of chronic venous insufficiency with low toxicity, minimal risk and few complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19912070      PMCID: PMC2787977          DOI: 10.1517/13543780903376163

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  42 in total

Review 1.  Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: joint statement of The American Venous Forum and The Society of Interventional Radiology.

Authors:  Sanjoy Kundu; Fedor Lurie; Steven F Millward; Frank Padberg; Suresh Vedantham; Steven Elias; Neil M Khilnani; William Marston; John F Cardella; Mark H Meissner; Michael C Dalsing; Timothy W I Clark; Robert J Min
Journal:  J Vasc Surg       Date:  2007-09       Impact factor: 4.268

Review 2.  Systematic review of foam sclerotherapy for varicose veins.

Authors:  X Jia; G Mowatt; J M Burr; K Cassar; J Cook; C Fraser
Journal:  Br J Surg       Date:  2007-08       Impact factor: 6.939

3.  More on microembolism and foam sclerotherapy.

Authors:  Janet E Rush; David D I Wright
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

4.  Microembolism during foam sclerotherapy of varicose veins.

Authors:  Roeland P M Ceulen; Anja Sommer; Kevin Vernooy
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

5.  Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.

Authors:  E Rabe; J Otto; D Schliephake; F Pannier
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-11-07       Impact factor: 7.069

6.  Major neurological events following foam sclerotherapy.

Authors:  R G Bush; M Derrick; D Manjoney
Journal:  Phlebology       Date:  2008       Impact factor: 1.740

7.  Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.

Authors:  Takashi Yamaki; Motohiro Nozaki; Hiyoyuki Sakurai; Masaki Takeuchi; Kazutaka Soejima; Taro Kono
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

8.  Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.

Authors:  F X Breu; S Guggenbichler; J C Wollmann
Journal:  Vasa       Date:  2008-02       Impact factor: 1.961

9.  The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro.

Authors:  K Parsi; T Exner; D E Connor; A Herbert; D D F Ma; J E Joseph
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-04-08       Impact factor: 7.069

10.  Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation.

Authors:  Nick Morrison; Diana L Neuhardt; Charles R Rogers; James McEown; Terri Morrison; Elaine Johnson; Sergio X Salles-Cunha
Journal:  J Vasc Surg       Date:  2008-02-01       Impact factor: 4.268

View more
  16 in total

1.  Life-threatening hematochezia from a rectal venous malformation successfully treated with microfoam sclerotherapy: description of a new technique.

Authors:  A Sierra; J Baixauli; T Elosúa; J Arredondo; J A Cienfuegos
Journal:  Int J Colorectal Dis       Date:  2015-01-29       Impact factor: 2.571

2.  A novel biomimetic analysis system for quantitative characterisation of sclerosing foams used for the treatment of varicose veins.

Authors:  Dario Carugo; Dyan N Ankrett; Vincent O'Byrne; Sean Willis; David D I Wright; Andrew L Lewis; Martyn Hill; Xunli Zhang
Journal:  J Mater Sci Mater Med       Date:  2013-03-20       Impact factor: 3.896

3.  Embolosclerotherapy by the Transvenous Approach for Lower Extremity Arteriovenous Malformation in Cowden Syndrome: A Case Report.

Authors:  Akiyuki Matsuhisa; Mitsuhiro Kishino; Masashi Nakadate; Toshifumi Kudo; Yoshinori Inoue; Ukihide Tateishi
Journal:  Ann Vasc Dis       Date:  2016-01-25

4.  Intraarterial polidocanol injection for the treatment of peripheral arteriovenous malformations.

Authors:  Onur Ergun; Eray Atlı; Bozkurt Gulek; Turkmen Ciftci; Barbaros Cil; Ibrahim Vargel; Bora Peynircioğlu
Journal:  Surg Today       Date:  2013-08-02       Impact factor: 2.549

Review 5.  Effective viral-mediated lung gene therapy: is airway surface preparation necessary?

Authors:  David Parsons; Martin Donnelley; Alexandra McCarron; Patricia Cmielewski; Victoria Drysdale
Journal:  Gene Ther       Date:  2022-03-29       Impact factor: 4.184

6.  Effects of 1064-nm Nd:YAG long-pulse laser on polidocanol microfoam injected for varicose vein treatment: a controlled observational study of 404 legs, after 5-year-long treatment.

Authors:  Javier Moreno-Moraga; Mihail L Pascu; Justo M Alcolea; Adriana Smarandache; Josefina Royo; Fernández David; Mario A Trelles
Journal:  Lasers Med Sci       Date:  2019-02-01       Impact factor: 3.161

7.  Acute renal failure, microangiopathic haemolytic anemia, and secondary oxalosis in a young female patient.

Authors:  Karolina M Stepien; Peter Prinsloo; Tony Hitch; Thomas A McCulloch; Rebecca Sims
Journal:  Int J Nephrol       Date:  2011-07-19

Review 8.  Interdisciplinary Management of Head and Neck Vascular Anomalies: Clinical Presentation, Diagnostic Findings and Minimalinvasive Therapies.

Authors:  Maliha Sadick; Walter A Wohlgemuth; Roland Huelse; Bettina Lange; Thomas Henzler; Stefan O Schoenberg; Haneen Sadick
Journal:  Eur J Radiol Open       Date:  2017-05-14

9.  The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein model.

Authors:  Dario Carugo; Dyan N Ankrett; Vincent O'Byrne; David D I Wright; Andrew L Lewis; Martyn Hill; Xunli Zhang
Journal:  J Mater Sci Mater Med       Date:  2015-10-08       Impact factor: 3.896

10.  A modified Tessari method for producing more foam.

Authors:  Jie Xu; Yi-Fei Wang; An-Wei Chen; Tao Wang; Shao-Hua Liu
Journal:  Springerplus       Date:  2016-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.